Abate Thomas M 4
4 · Edwards Lifesciences Corp · Filed Apr 26, 2013
Insider Transaction Report
Form 4
Abate Thomas M
CVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2013-04-26$64.41/sh−8,800$566,808→ 46,688.976 total - Sale
Common Stock
2013-04-26$65.36/sh−1,200$78,432→ 55,488.976 total - Exercise/Conversion
Common Stock
2013-04-26$21.95/sh+10,000$219,550→ 56,688.976 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-04-26−10,000→ 15,000 totalExercise: $21.95From: 2007-05-11Exp: 2013-05-10→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $65.14 to $65.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $64.05 to $64.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.